Altitude
Quick Trip or Daily Practice: The Brain Doesn't Care How You Get There
Neuroscience

Quick Trip or Daily Practice: The Brain Doesn't Care How You Get There

Nathan Richardson • Aug 10, 2026

Psilocybin's calling card on an MRI is a quieted default mode network and a burst of new neural connections. A growing body of research says meditation and the vagus nerve reach some of the same systems — on a different timeline. The evidence points to complementary paths, not competing ones.

TL;DR

  • Personal Element: My own sequence — the psilocybin retreat first, the daily meditation habit built after — now taught to my kids in five-minute doses.
  • What It Means: Psilocybin and meditation aren't competing paths. They're complementary, hitting the same brain systems on different timelines.
  • Proof or Evidence: Imperial College London and Yale imaging studies on the default mode network, and the FDA-approved vagus-nerve device built on the same mechanism.

A few months ago I wrote about starting a meditation practice — Headspace to get the habit going, then Joe Dispenza's guided sessions for something more intense. Since then I've mostly moved to Insight Timer, which turned out to be less an app and more a library. I've been working my way through teachers there — David Ji, Darius, a rotating cast of others — the way you'd sample different gyms before picking one. Some sessions are concentration-based, some are loving-kindness, some are just sitting with whatever comes up.

I've also started doing five or ten minutes with my kids, separate from any of that — a short visualization practice where they picture themselves succeeding at whatever's coming up that week, a race, a game, a hard conversation. Half of it is performance rehearsal. Half of it is just giving them a tool for the moment before their emotions run the show instead of them.

None of this involves a compound. No psilocybin, no ceremony, no guide checking my vitals. And yet the more I read about what's actually happening in the brain during a session — mine or the kids' — the more it looks like it's reaching for some of the same switches that psilocybin and 5-MeO-DMT get credit for flipping. I went through the psilocybin retreat too. So the question I keep circling is not which of these is "real." It's whether the quick trip and the daily practice are doing the same underlying work, on different timelines, in a way that makes them additive rather than competing.

That's a claim worth being careful with, so what follows is the actual evidence — what's shared, what isn't, and where the vagus nerve fits into a story that usually treats meditation and psychedelics as two separate conversations.

What Psychedelics Actually Look Like on an MRI

The signature finding, the one that shows up across nearly every psilocybin imaging study since the field restarted, is a quieted default mode network. The DMN is the set of brain regions — medial prefrontal cortex, posterior cingulate cortex, among others — that lights up when you're not doing anything in particular: mind-wandering, ruminating, running the internal narrative of "me." It's also the network that's overactive in depression and anxiety.

Robin Carhart-Harris and colleagues at Imperial College London showed in a 2012 PNAS study that psilocybin reduces coordinated activity within the DMN while sharply increasing connectivity between networks that don't normally talk to each other — regions that are usually walled off suddenly cross-communicating. The degree of DMN disruption tracked with how strongly people reported "ego dissolution." Separately, as I've written about here before, single doses of psilocybin have been linked to measurable increases in dendritic spine density in the frontal cortex — new physical connections between neurons, not just a change in activity — via the BDNF and mTOR signaling pathways that drive neuroplasticity.

That's the bar: quiet the self-referential network, open up cross-talk between distant brain regions, and trigger the molecular machinery that builds new synapses. Fast, intense, chemically driven.

Meditation Reaches the Same Switch

Judson Brewer and colleagues at Yale put experienced meditators and meditation-naive controls in an fMRI scanner in a 2011 PNAS study and had them run through several different practices — concentration, loving-kindness, choiceless awareness. Across every style, the experienced meditators showed the same thing: deactivation of the DMN's main nodes, the medial prefrontal and posterior cingulate cortices. Not one technique doing it. The trait of being an experienced meditator doing it, regardless of which door they walked through.

Sara Lazar's group at Harvard and Massachusetts General Hospital found something structural to go with it. Their 2005 NeuroReport study measured cortical thickness in longtime Insight meditation practitioners and found measurably thicker tissue in the prefrontal cortex and right anterior insula — regions tied to attention and interoception — with the difference most pronounced in older meditators, suggesting the practice was offsetting the cortical thinning that normally comes with age.

Different mechanism, similar destination. No 5-HT2A receptor involved. Just attention, repeated, for months or years, doing something to the DMN that a single afternoon on psilocybin also does.

The Vagus Nerve: The Machinery Underneath

Here's the part of this story that rarely gets told alongside meditation and psychedelics, because it doesn't sound as interesting on its own: a wandering cranial nerve running from your brainstem down through your neck, chest, and gut, carrying signals in both directions — about 80% of its fibers run body-to-brain, not the other way around. It's the physical link between what's happening in your gut and heart and what your brain does with that information.

We know the vagus nerve can drive real neuroplasticity because it now sits inside an FDA-approved medical device. Michael Kilgard's lab at UT Dallas built the foundational finding: stimulate the vagus nerve at the same moment an animal performs a specific movement or hears a specific tone, and the pairing releases norepinephrine and acetylcholine in the brain that strengthens exactly the synaptic connections involved in that task. Repeated pairing rewires the relevant circuit.

That research became a stroke rehabilitation device. The VNS-REHAB trial, a 108-person randomized, blinded pivotal study published in The Lancet in April 2021, paired vagus nerve stimulation with arm rehabilitation exercises in chronic stroke patients — people at least nine months out from their stroke, past the window where recovery is supposed to plateau. 47% of the VNS group hit a clinically meaningful improvement in arm function, against 24% on sham stimulation paired with the same exercises. The FDA approved the device — MicroTransponder's Vivistim — on August 31, 2021, for moderate-to-severe upper-limb motor deficits after chronic ischemic stroke. That's a nerve, stimulated on purpose, producing new motor circuitry in a brain that had otherwise stopped improving.

You Don't Need an Implant

Vivistim requires a surgically implanted lead wrapped around the vagus nerve in the neck. But the vagus nerve also surfaces at the ear, and stimulating it there — transcutaneous auricular VNS, taVNS — turns out to reach a lot of the same territory without surgery.

Eleni Frangos and colleagues showed in a 2015 fMRI study that electrical stimulation of the ear activates the same central vagal projections invasive stimulation does — the nucleus tractus solitarius, the locus coeruleus, the insula, hippocampus, amygdala, and thalamus. The locus coeruleus matters here specifically: it's the brain's main source of norepinephrine, the same neuromodulator Kilgard's pairing mechanism runs on.

And it moves the network we've been talking about. A 2016 Biological Psychiatry study by Fang and colleagues found that four weeks of taVNS in patients with major depressive disorder increased functional connectivity between the default mode network and prefrontal regions that are disrupted in depression — and that increase tracked with symptom improvement. Different entry point than a psilocybin session or a decade of sitting practice. Same network, moving in a direction that correlates with people feeling better.

Breath and Cold: Vagus Nerve Without Any Device at All

This is where Wim Hof's method earns more credibility than its wellness-influencer packaging suggests. A 2014 PNAS study by Kox and colleagues at Radboud University Medical Center took people Wim Hof had trained in his combination of breathing exercises, cold exposure, and meditation, injected them with bacterial endotoxin — something that reliably produces flu-like inflammatory symptoms — and compared them to untrained controls getting the same injection. The trained group produced 50 to 70% fewer inflammatory cytokines and reported milder symptoms. They had, under laboratory conditions, voluntary influence over a part of the immune and autonomic nervous system that was assumed to be automatic.

The breathing component alone — rapid deep breaths followed by a breath hold — appears to work independently of the cold, through a burst of norepinephrine release during the breath hold following the hyperventilation phase. That's not a default-mode-network finding; the Kox study measured immune markers and autonomic activation, not brain connectivity. But it's the same underlying axis: breath and cold as a lever on the sympathetic nervous system and the vagus nerve, without a chemical or a device.

What's Actually the Same, and What Isn't

I want to be precise about this rather than overstate it, because the honest version is more interesting than the tidy one — and it's also the version that supports "complementary," not the version that supports "interchangeable."

Psilocybin's effect is fast, intense, and comes from directly agonizing a serotonin receptor that triggers dendritic growth within hours, in a single session. Meditation's DMN effect, per Brewer's study, shows up as a trait in people with sustained practice — it's not something a single ten-minute sitting reliably produces the way one dose of psilocybin produces its signature. VNS is targeted and mechanical — a specific pairing of stimulation with a specific task, engineered to strengthen a specific circuit, and its best evidence is in stroke rehab and depression, not general cognitive enhancement. Wim Hof-style breathwork has real autonomic and immune evidence but doesn't yet have the direct default-mode-network imaging data the other three have.

What's genuinely shared is the target, not the intensity: the default mode network, and the norepinephrine/acetylcholine machinery the locus coeruleus and vagus nerve run on, are general levers on a more flexible brain — not switches that only a scheduled compound can reach. That's exactly why they stack instead of substitute. A psilocybin session forces the DMN quiet and floods the brain with plasticity signaling for one intense window. A daily meditation or breath practice keeps nudging the same network in the same direction, in small doses, for the other 364 days of the year. One doesn't make the other redundant. Romain Nardou and colleagues reported in a 2023 Nature study that psilocybin, LSD, ketamine, and ibogaine each reopen a "critical period" of heightened social-learning plasticity in mice, lasting anywhere from 48 hours to four weeks depending on the compound — a temporary window where the brain is unusually receptive to new learning. If something like that window exists, the daily practice is exactly what should fill it: the thing that gives a temporarily reopened brain somewhere useful to go.

Where This Leaves Me — and the Kids

I don't know whether five or ten minutes of visualization with an eight- and eleven-year-old shows up on an fMRI the way Brewer's meditators did — nobody has scanned a kid mid-manifestation before a soccer game, and I'm not going to pretend the study exists. What the evidence above does tell me is that the underlying systems — a default mode network that can be trained to quiet down, a vagus nerve that responds to attention and breath the same way it responds to a stimulator — aren't exotic. They're trainable, on a timeline of months and years, using nothing more unusual than sitting still and breathing on purpose.

My own path ran the other direction from most people's: the quick trip first, on a mat at a retreat, then the daily practice built up slowly afterward — Headspace, Dispenza, now Insight Timer. Looking at the research side by side, I don't think that sequence was an accident, and I don't think either half of it did the whole job alone. Want to chip away at an overactive default mode network? Want to give your neurons more reason to fire and wire together? The evidence says the quick trip and the daily practice are both legitimate ways in — different speeds, same direction, and probably better together than either one running solo. Which is the version of this I'm actually trying to build for my kids: not a substitute for anything, just an early, unglamorous head start on a system that psilocybin can also, later, open the door to faster.

This article is for educational purposes only and does not constitute medical advice. It is not a claim that meditation, vagus nerve stimulation, or breathwork produce the same clinical outcomes as psilocybin or 5-MeO-DMT, which remain under clinical investigation and are not FDA-approved treatments. Vagus nerve stimulation devices discussed here, including Vivistim, are approved for specific medical indications and require a prescription and clinical supervision; consult a qualified clinician before pursuing any of the practices described.

Sources

← Back to Journal